<bill session="116" type="h" number="7839" updated="2023-01-11T13:45:48Z">
  <state datetime="2020-07-29">REFERRED</state>
  <status>
    <introduced datetime="2020-07-29"/>
  </status>
  <introduced datetime="2020-07-29"/>
  <titles>
    <title type="display">Continuing Access to In-Home IVIG Act</title>
    <title type="short" as="introduced">Continuing Access to In-Home IVIG Act</title>
    <title type="official" as="introduced">To amend the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Patient IVIG Access Demonstration Project.</title>
  </titles>
  <sponsor bioguide_id="M001163"/>
  <cosponsors>
    <cosponsor bioguide_id="B000755" joined="2020-07-29"/>
    <cosponsor bioguide_id="B001251" joined="2020-10-23"/>
    <cosponsor bioguide_id="C001055" joined="2020-09-21"/>
    <cosponsor bioguide_id="C001053" joined="2020-09-29"/>
    <cosponsor bioguide_id="H001090" joined="2020-09-29"/>
    <cosponsor bioguide_id="H001065" joined="2020-10-23"/>
    <cosponsor bioguide_id="J000032" joined="2020-10-23"/>
    <cosponsor bioguide_id="K000385" joined="2020-09-30"/>
    <cosponsor bioguide_id="K000381" joined="2020-12-08"/>
    <cosponsor bioguide_id="N000179" joined="2020-10-23"/>
    <cosponsor bioguide_id="S001183" joined="2020-09-21"/>
    <cosponsor bioguide_id="S001172" joined="2020-10-16"/>
    <cosponsor bioguide_id="W000815" joined="2020-09-16"/>
  </cosponsors>
  <actions>
    <action datetime="2020-07-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-07-29" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-07-29">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-07-29">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Government studies and investigations"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Hereditary and development disorders"/>
    <term name="Home and outpatient care"/>
    <term name="Immunology and vaccination"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2020-10-19T19:31:32Z" status="Introduced in House">Continuing Access to In-Home IVIG Act

This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.</summary>
</bill>
